You are viewing content for the region United States

Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.

Change to Canada »
Remain viewing United States »

This website is intended for US Healthcare Professionals only

About DigiFab®

DigiFab® Digoxin Immune Fab (Ovine) is a sterile, purified, lyophilized preparation of digoxin-immune ovine Fab (monovalent) immunoglobulin fragments.1

Each vial of DigiFab® Digoxin Immune Fab (Ovine), which will bind approximately 0.5 mg digoxin, contains 40 mg of digoxin immune Fab, 75 mg (approx) of mannitol USP, and 2 mg (approx) sodium acetate USP as a buffering agent.1

The product contains no preservatives and is intended for intravenous administration after reconstitution with 4 mL of Sterile Water for Injection USP.1

DigiFab® Digoxin Immune Fab (Ovine)1:

  • Rapidly binds to and neutralizes digoxin with measurable results
    • Rapidly reduces levels of free digoxin to undetectable2
    • More than 40% of digoxin excreted by 24 hours
    • 93% of patients resolved their digoxin poisoning by 20 hours
Read about how DigiFab® is produced »
Read about mechanism of action of DigiFab® »
Read about the efficacy and risks of DigiFab® »

References

  1. DigiFab® [prescribing information]. BTG International Inc. January 2012.
  2. Ward SB, Sjostrom L, Ujhelyi MR. Comparison of the Pharmacokinetics and In Vivo Bioaffinity of DigiTAb Versus Digibind. Ther Drug Monit 2000;22(5):599-607.

To report an adverse event or for 24-hour medical information, call 1-877-377-3784